Published by Align Wellness
Testosterone, menopause, perimenopause and the endocrine shifts of midlife, explained with the latest trials and guidelines.
AnalysisLabel Change
In November 2025, regulators removed most of the boxed warning that had defined hormone therapy since 2002. The science behind the shift is about timing, and the remaining risks are still worth a real conversation.
AnalysisMen's Health
For a decade, the heart-risk question hung over testosterone therapy. A 5,246-man randomized trial answered a lot of it. It also raised new questions about who should be treated and how.
ExplainerThyroid
Mildly elevated TSH with normal thyroid hormone is common after 60. A large European trial found that treating it in older adults did not improve how people felt.
AnalysisOcean State Field Notes
ExplainerFitness Is Fate
GuideNarragansett Bay
AnalysisWeight Medicine
